Probiotics, prebiotics, and synbiotics: implications and beneficial effects against irritable bowel syndrome
There you can claim your profile and add verified company/contact details
Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist
This combination of semaglutide, which mimics the GLP-1 hormone, and cagrilintide, which targets another hormone, amylin, aims to provide enhanced efficacy without increased side effects
Tissue Repair Compound Research blend of BPC-157 (15-mer gastric pentadecapeptide) and TB-500 (thymosin -4 actin-binding fragment) for comparative tissue-pathway studies in vitro
Figure 2: Changes in body weight from baseline to the end of treatment at week 26 associated with the treatment policy estimand, in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo